메뉴 건너뛰기




Volumn 11, Issue 2, 2014, Pages 553-562

Patient satisfaction with testosterone replacement therapies: The reasons behind the choices

Author keywords

Male Hypogonadism; Patient Preferences; Patient Satisfaction; Testosterone Replacement Therapy

Indexed keywords

TESTOSTERONE;

EID: 84907080949     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/jsm.12369     Document Type: Article
Times cited : (38)

References (55)
  • 4
    • 84873060198 scopus 로고    scopus 로고
    • The 20-year public health impact and direct cost of testosterone deficiency in U.S. men
    • Moskovic DJ, Araujo AB, Lipshultz LI, Khera M. The 20-year public health impact and direct cost of testosterone deficiency in U.S. men. J Sex Med 2013;10:562-569.
    • (2013) J Sex Med , vol.10 , pp. 562-569
    • Moskovic, D.J.1    Araujo, A.B.2    Lipshultz, L.I.3    Khera, M.4
  • 5
    • 84872852291 scopus 로고    scopus 로고
    • Testosterone deficiency in men: Systematic review and standard operating procedures for diagnosis and treatment
    • Buvat J, Maggi M, Guay A, Torres LO. Testosterone deficiency in men: Systematic review and standard operating procedures for diagnosis and treatment. J Sex Med 2013;10:245-284.
    • (2013) J Sex Med , vol.10 , pp. 245-284
    • Buvat, J.1    Maggi, M.2    Guay, A.3    Torres, L.O.4
  • 7
    • 68149178808 scopus 로고    scopus 로고
    • Welcoming low testosterone as a cardiovascular risk factor
    • Maggio M, Basaria S. Welcoming low testosterone as a cardiovascular risk factor. Int J Impot Res 2009;21:261-264.
    • (2009) Int J Impot Res , vol.21 , pp. 261-264
    • Maggio, M.1    Basaria, S.2
  • 8
    • 84866166373 scopus 로고    scopus 로고
    • Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?
    • Giannoulis MG, Martin FC, Nair KS, Umpleby AM, Sonksen P. Hormone replacement therapy and physical function in healthy older men. Time to talk hormones? Endocr Rev 2012;33:314-377.
    • (2012) Endocr Rev , vol.33 , pp. 314-377
    • Giannoulis, M.G.1    Martin, F.C.2    Nair, K.S.3    Umpleby, A.M.4    Sonksen, P.5
  • 9
    • 26444515048 scopus 로고    scopus 로고
    • The decline of androgen levels in elderly men and its clinical and therapeutic implications
    • Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 2005;26:833-876.
    • (2005) Endocr Rev , vol.26 , pp. 833-876
    • Kaufman, J.M.1    Vermeulen, A.2
  • 10
    • 33751533215 scopus 로고    scopus 로고
    • Association of specific symptoms and metabolic risks with serum testosterone in older men
    • Zitzmann M, Faber S, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 2006;91:4335-4343.
    • (2006) J Clin Endocrinol Metab , vol.91 , pp. 4335-4343
    • Zitzmann, M.1    Faber, S.2    Nieschlag, E.3
  • 11
    • 33644828241 scopus 로고    scopus 로고
    • Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men
    • Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab 2006;91:843-850.
    • (2006) J Clin Endocrinol Metab , vol.91 , pp. 843-850
    • Kupelian, V.1    Page, S.T.2    Araujo, A.B.3    Travison, T.G.4    Bremner, W.J.5    McKinlay, J.B.6
  • 12
    • 43949086558 scopus 로고    scopus 로고
    • Low serum testosterone in men is inversely associated with non-fasting serum triglycerides: The Tromso study
    • Agledahl I, Skjaerpe PA, Hansen JB, Svartberg J. Low serum testosterone in men is inversely associated with non-fasting serum triglycerides: The Tromso study. Nutr Metab Cardiovasc Dis 2008;18:256-262.
    • (2008) Nutr Metab Cardiovasc Dis , vol.18 , pp. 256-262
    • Agledahl, I.1    Skjaerpe, P.A.2    Hansen, J.B.3    Svartberg, J.4
  • 13
  • 18
    • 74049143811 scopus 로고    scopus 로고
    • Symptomatic response rates to testosterone therapy and the likelihood of completing 12 months of therapy in clinical practice
    • Rhoden EL, Morgentaler A. Symptomatic response rates to testosterone therapy and the likelihood of completing 12 months of therapy in clinical practice. J Sex Med 2010;7:277-283.
    • (2010) J Sex Med , vol.7 , pp. 277-283
    • Rhoden, E.L.1    Morgentaler, A.2
  • 19
    • 0036220738 scopus 로고    scopus 로고
    • Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: A phase II study
    • von Eckardstein S, Nieschlag E. Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: A phase II study. J Androl 2002;23:419-425.
    • (2002) J Androl , vol.23 , pp. 419-425
    • von Eckardstein, S.1    Nieschlag, E.2
  • 20
    • 84856530228 scopus 로고    scopus 로고
    • A multi-institutional observational study of testosterone levels after testosterone pellet (Testopel®) insertion
    • McCullough AR, Khera M, Goldstein I, Hellstrom WJ, Morgentaler A, Levine LA. A multi-institutional observational study of testosterone levels after testosterone pellet (Testopel®) insertion. J Sex Med 2012;9:594-601.
    • (2012) J Sex Med , vol.9 , pp. 594-601
    • McCullough, A.R.1    Khera, M.2    Goldstein, I.3    Hellstrom, W.J.4    Morgentaler, A.5    Levine, L.A.6
  • 22
    • 0038410330 scopus 로고    scopus 로고
    • Evaluation of the pharmacokinetic profiles of the new testosterone topical gel formulation, Testim, compared to AndroGel
    • Marbury T, Hamill E, Bachand R, Sebree T, Smith T. Evaluation of the pharmacokinetic profiles of the new testosterone topical gel formulation, Testim, compared to AndroGel. Biopharm Drug Dispos 2003;24:115-120.
    • (2003) Biopharm Drug Dispos , vol.24 , pp. 115-120
    • Marbury, T.1    Hamill, E.2    Bachand, R.3    Sebree, T.4    Smith, T.5
  • 23
    • 40649125607 scopus 로고    scopus 로고
    • Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men
    • Grober ED, Khera M, Soni SD, Espinoza MG, Lipshultz LI. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men. Int J Impot Res 2008;20:213-217.
    • (2008) Int J Impot Res , vol.20 , pp. 213-217
    • Grober, E.D.1    Khera, M.2    Soni, S.D.3    Espinoza, M.G.4    Lipshultz, L.I.5
  • 24
    • 0023194264 scopus 로고
    • Hormone kinetics after intramuscular testosterone cypionate
    • Nankin HR. Hormone kinetics after intramuscular testosterone cypionate. Fertil Steril 1987;47:1004-1009.
    • (1987) Fertil Steril , vol.47 , pp. 1004-1009
    • Nankin, H.R.1
  • 25
    • 84883559843 scopus 로고    scopus 로고
    • Factors influencing patient decisions to initiate and discontinue subcutaneous testosterone pellets (Testopel®) for treatment of hypogonadism
    • Smith RP, Khanna A, Coward RM, Rajanahally S, Kovac JR, Gonzales MA, Lipshultz LI. Factors influencing patient decisions to initiate and discontinue subcutaneous testosterone pellets (Testopel®) for treatment of hypogonadism. J Sex Med 2013;10:2326-2333.
    • (2013) J Sex Med , vol.10 , pp. 2326-2333
    • Smith, R.P.1    Khanna, A.2    Coward, R.M.3    Rajanahally, S.4    Kovac, J.R.5    Gonzales, M.A.6    Lipshultz, L.I.7
  • 26
    • 84875443438 scopus 로고    scopus 로고
    • The evidence for seasonal variations of testosterone in men
    • Smith RP, Coward RM, Kovac JR, Lipshultz LI. The evidence for seasonal variations of testosterone in men. Maturitas 2013;pii: S0378-5122(12)00403-3. doi: 10.1016/j.maturitas.2012.12.003.
    • (2013) Maturitas
    • Smith, R.P.1    Coward, R.M.2    Kovac, J.R.3    Lipshultz, L.I.4
  • 28
    • 2442543161 scopus 로고    scopus 로고
    • Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men
    • Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, Weber T, Berman N, Hull L, Swerdloff RS. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 2004;89:2085-2098.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 2085-2098
    • Wang, C.1    Cunningham, G.2    Dobs, A.3    Iranmanesh, A.4    Matsumoto, A.M.5    Snyder, P.J.6    Weber, T.7    Berman, N.8    Hull, L.9    Swerdloff, R.S.10
  • 29
    • 33947169475 scopus 로고    scopus 로고
    • Improvement of sexual function in men with late-onset hypogonadism treated with testosterone only
    • Yassin AA, Saad F. Improvement of sexual function in men with late-onset hypogonadism treated with testosterone only. J Sex Med 2007;4:497-501.
    • (2007) J Sex Med , vol.4 , pp. 497-501
    • Yassin, A.A.1    Saad, F.2
  • 31
    • 33845762711 scopus 로고    scopus 로고
    • Testosterone and men's quality of life
    • Moncada I. Testosterone and men's quality of life. Aging Male 2006;9:189-193.
    • (2006) Aging Male , vol.9 , pp. 189-193
    • Moncada, I.1
  • 32
    • 69949178483 scopus 로고    scopus 로고
    • Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone
    • Heufelder AE, Saad F, Bunck MC, Gooren L. Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone. J Androl 2009;30:726-733.
    • (2009) J Androl , vol.30 , pp. 726-733
    • Heufelder, A.E.1    Saad, F.2    Bunck, M.C.3    Gooren, L.4
  • 33
    • 77949503625 scopus 로고    scopus 로고
    • Improvement of the metabolic syndrome and of non-alcoholic liver steatosis upon treatment of hypogonadal elderly men with parenteral testosterone undecanoate
    • Haider A, Gooren LJ, Padungtod P, Saad F. Improvement of the metabolic syndrome and of non-alcoholic liver steatosis upon treatment of hypogonadal elderly men with parenteral testosterone undecanoate. Exp Clin Endocrinol Diabetes 2010;118:167-171.
    • (2010) Exp Clin Endocrinol Diabetes , vol.118 , pp. 167-171
    • Haider, A.1    Gooren, L.J.2    Padungtod, P.3    Saad, F.4
  • 35
    • 84859509755 scopus 로고    scopus 로고
    • Testosterone treatment in the aging male: Myth or reality?
    • Nigro N, Christ-Crain M. Testosterone treatment in the aging male: Myth or reality? Swiss Med Wkly 2012;142:w13539.
    • (2012) Swiss Med Wkly , vol.142 , pp. w13539
    • Nigro, N.1    Christ-Crain, M.2
  • 36
    • 77949426910 scopus 로고    scopus 로고
    • The benefits and risks of testosterone replacement therapy: A review
    • Bassil N, Alkaade S, Morley JE. The benefits and risks of testosterone replacement therapy: A review. Ther Clin Risk Manag 2009;5:427-448.
    • (2009) Ther Clin Risk Manag , vol.5 , pp. 427-448
    • Bassil, N.1    Alkaade, S.2    Morley, J.E.3
  • 38
    • 58449105426 scopus 로고    scopus 로고
    • Hyperandrogenism after transfer of topical testosterone gel: Case report and review of published and unpublished studies
    • de Ronde W. Hyperandrogenism after transfer of topical testosterone gel: Case report and review of published and unpublished studies. Hum Reprod 2009;24:425-428.
    • (2009) Hum Reprod , vol.24 , pp. 425-428
    • de Ronde, W.1
  • 40
    • 0037236825 scopus 로고    scopus 로고
    • A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function
    • McNicholas TA, Dean JD, Mulder H, Carnegie C, Jones NA. A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function. BJU Int 2003;91:69-74.
    • (2003) BJU Int , vol.91 , pp. 69-74
    • McNicholas, T.A.1    Dean, J.D.2    Mulder, H.3    Carnegie, C.4    Jones, N.A.5
  • 45
    • 80054827093 scopus 로고    scopus 로고
    • Onset of effects of testosterone treatment and time span until maximum effects are achieved
    • Saad F, Aversa A, Isidori AM, Zafalon L, Zitzmann M, Gooren L. Onset of effects of testosterone treatment and time span until maximum effects are achieved. Eur J Endocrinol 2011;165:675-685.
    • (2011) Eur J Endocrinol , vol.165 , pp. 675-685
    • Saad, F.1    Aversa, A.2    Isidori, A.M.3    Zafalon, L.4    Zitzmann, M.5    Gooren, L.6
  • 47
    • 0035160713 scopus 로고    scopus 로고
    • Treatment options for a patient experiencing pruritic rash associated with transdermal testosterone: A review of the literature
    • McGriff NJ, Csako G, Kabbani M, Diep L, Chrousos GP, Pucino F. Treatment options for a patient experiencing pruritic rash associated with transdermal testosterone: A review of the literature. Pharmacotherapy 2001;21:1425-1435.
    • (2001) Pharmacotherapy , vol.21 , pp. 1425-1435
    • McGriff, N.J.1    Csako, G.2    Kabbani, M.3    Diep, L.4    Chrousos, G.P.5    Pucino, F.6
  • 49
    • 84876969942 scopus 로고    scopus 로고
    • Medication adherence and treatment patterns for hypogonadal patients treated with topical testosterone therapy: A retrospective medical claims analysis
    • Schoenfeld MJ, Shortridge E, Cui Z, Muram D. Medication adherence and treatment patterns for hypogonadal patients treated with topical testosterone therapy: A retrospective medical claims analysis. J Sex Med 2013;10:1401-1409.
    • (2013) J Sex Med , vol.10 , pp. 1401-1409
    • Schoenfeld, M.J.1    Shortridge, E.2    Cui, Z.3    Muram, D.4
  • 50
    • 63149194127 scopus 로고    scopus 로고
    • Testosterone gel monotherapy improves sexual function of hypogonadal men mainly through restoring erection: Evaluation by IIEF score
    • Chiang HS, Cho SL, Lin YC, Hwang TI. Testosterone gel monotherapy improves sexual function of hypogonadal men mainly through restoring erection: Evaluation by IIEF score. Urology 2009;73:762-766.
    • (2009) Urology , vol.73 , pp. 762-766
    • Chiang, H.S.1    Cho, S.L.2    Lin, Y.C.3    Hwang, T.I.4
  • 51
    • 68049144803 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled study of testosterone treatment in hypogonadal older men with subthreshold depression (dysthymia or minor depression)
    • Shores MM, Kivlahan DR, Sadak TI, Li EJ, Matsumoto AM. A randomized, double-blind, placebo-controlled study of testosterone treatment in hypogonadal older men with subthreshold depression (dysthymia or minor depression). J Clin Psychiatry 2009;70:1009-1016.
    • (2009) J Clin Psychiatry , vol.70 , pp. 1009-1016
    • Shores, M.M.1    Kivlahan, D.R.2    Sadak, T.I.3    Li, E.J.4    Matsumoto, A.M.5
  • 52
    • 84878704250 scopus 로고    scopus 로고
    • Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes
    • Hackett G, Cole N, Bhartia M, Kennedy D, Raju J, Wilkinson P. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes. J Sex Med 2013;10:1612-1627.
    • (2013) J Sex Med , vol.10 , pp. 1612-1627
    • Hackett, G.1    Cole, N.2    Bhartia, M.3    Kennedy, D.4    Raju, J.5    Wilkinson, P.6
  • 53
    • 84890063675 scopus 로고    scopus 로고
    • Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss
    • Yassin AA, Doros G. Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss. Clin Obes 2013;3:73-83.
    • (2013) Clin Obes , vol.3 , pp. 73-83
    • Yassin, A.A.1    Doros, G.2
  • 54
    • 84885371224 scopus 로고    scopus 로고
    • Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss
    • Silver Spring
    • Saad F, Haider A, Doros G, Traish A. Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss. Obesity (Silver Spring) 2013;21:1975-1981.
    • (2013) Obesity , vol.21 , pp. 1975-1981
    • Saad, F.1    Haider, A.2    Doros, G.3    Traish, A.4
  • 55
    • 51649103492 scopus 로고    scopus 로고
    • Serum testosterone and bioavailable testosterone correlate with age and body size in hypogonadal men treated with testosterone undecanoate (1,000mg IM-Nebido)
    • Moisey R, Swinburne J, Orme S. Serum testosterone and bioavailable testosterone correlate with age and body size in hypogonadal men treated with testosterone undecanoate (1, 000mg IM-Nebido). Clin Endocrinol (Oxf) 2008;69:642-647.
    • (2008) Clin Endocrinol (Oxf) , vol.69 , pp. 642-647
    • Moisey, R.1    Swinburne, J.2    Orme, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.